IMOMEDIUM SIGNALFINANCIAL10-K

IMO reported a significant 31.8% decline in net income despite strong operating cash flow growth, accompanied by substantial increases in share buybacks and SG&A expenses.

The sharp drop in net income from $4.8B to $3.3B, combined with a 46.7% surge in SG&A expenses, suggests either increased operational costs or potentially one-time charges that warrant investor scrutiny. However, the 12.2% growth in operating cash flow and 70.7% reduction in interest expense indicate underlying operational strength and improved capital efficiency.

Comparing 2026-02-18 vs 2025-02-19View on EDGAR →
FINANCIAL ANALYSIS

IMO's financial profile shows mixed signals with strong cash generation (operating cash flow up 12.2% to $6.7B) and improved financial position (interest expense down 70.7%, cash up 16.6%), but profitability pressures from a significant net income decline of 31.8% to $3.3B and elevated SG&A costs rising 46.7% to $1.4B. The company responded by increasing share buybacks 20.6% to $3.2B, suggesting management confidence in the business despite near-term earnings headwinds. The overall picture indicates a company with solid cash generation capacity managing through a challenging earnings environment while returning substantial capital to shareholders.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
-70.7%
$41.0M→$12.0M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

SG&A Expense
P&L
+46.7%
$945.0M→$1.4B

SG&A up 46.7% — significant increase in sales or administrative costs, monitor impact on operating leverage.

Net Income
P&L
-31.8%
$4.8B→$3.3B

Net income declined 31.8% — review whether driven by operations, interest costs, or non-recurring items.

Share Buybacks
Cash Flow
+20.6%
$2.7B→$3.2B

Share repurchases increased 20.6% — management returning capital, signals confidence in intrinsic value.

Cash & Equivalents
Balance Sheet
+16.6%
$979.0M→$1.1B

Cash grew 16.6% — improving liquidity position supports investment and shareholder returns.

R&D Expense
P&L
+13.6%
$118.0M→$134.0M

R&D investment increased 13.6% — signals commitment to future product development, though near-term margin impact.

Operating Cash Flow
Cash Flow
+12.2%
$6.0B→$6.7B

Operating cash flow grew 12.2% — strong conversion of earnings to cash, healthy business fundamentals.

Current Assets
Balance Sheet
-10%
$9.4B→$8.4B

Current assets declined 10% — monitor working capital adequacy and short-term liquidity.

LANGUAGE CHANGES
NEW — 2026-02-18
PRIOR — 2025-02-19
ADDED
13,534 14,654 16,166 (b) Amounts to related parties included in purchases of crude oil and products (note 16).
5,369 6,651 6,747 (c) Amounts to related parties included in production and manufacturing, and selling and general expenses (note 16).
251 266 (c) Long-term debt included amounts to related parties (note 16).
$ 484 $ 509 (c) Includes contributions to registered pension plans.
The number of common shares outstanding, as of February 11, 2026, was 483,592,715 .
Liquids (a) Natural gas Synthetic crude oil Bitumen Total oil-equivalent basis millions of barrels billions of cubic feet millions of barrels millions of barrels millions of barrels Net proved reserves: Developed 41 288 1,641 1,936 Undeveloped 8 99 100 Total net proved 49 288 1,740 2,036 (a) Liquids include crude oil and natural gas liquids (NGLs).
Although the company is reasonably certain that proved reserves will be produced, the timing and amount recovered can be affected by a number of factors, including completion and optimization of development projects, reservoir performance, and facility processing capacity.
During the last 5 years, the majority of such evaluator's time was spent evaluating resources.
The company s internal reserves evaluation staff consists of 20 persons with professional designations, with an average of 13 years engaged with the company's resource evaluation.
The company s internal reserves evaluation management team is made up of 12 persons with an average of 10 years engaged with the company's resource evaluation.
REMOVED
11,725 13,544 17,042 (b) Amounts to related parties included in purchases of crude oil and products (note 16).
3,722 4,125 3,795 (c) Amounts to related parties included in production and manufacturing, and selling and general expenses (note 16).
266 283 (c) Long-term debt included amounts to related parties (note 16).
$ 509 $ 536 (b) Included contributions to registered pension plans.
The number of common shares outstanding, as of February 14, 2025, was 509,044,963 .
Liquids (a) Natural gas Synthetic crude oil Bitumen Total oil-equivalent basis millions of barrels billions of cubic feet millions of barrels millions of barrels millions of barrels Net proved reserves: Developed 41 190 1,697 1,894 Undeveloped 12 106 119 227 Total net proved 53 296 1,816 2,121 (a) Liquids include crude oil, condensate and natural gas liquids (NGLs).
Although the company is reasonably certain that proved reserves will be produced, the timing and amount recovered can be affected by a number of factors, including completion and optimization of development projects, reservoir performance, regulatory approvals, government policies, consumer preferences, changes in the amount and timing of capital investments, royalty frameworks and significant changes in oil and gas price levels.
The company s internal reserves evaluation staff consists of 22 persons with an average of 12 years of relevant technical experience in evaluating reserves, of whom 21 persons are qualified reserves evaluators for purposes of Canadian securities regulatory requirements.
The company s internal reserves evaluation management team is made up of 15 persons with an average of 10 years of relevant experience in evaluating and managing the evaluation of reserves.
Proved undeveloped reserves As at December 31, 2024, approximately 11 percent of the company s proved reserves were proved undeveloped reflecting volumes of 227 million oil-equivalent barrels.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →